Contact this trialFirst, we need to learn more about you.
Ganaxolone for Tuberous Sclerosis-Related Epilepsy
Recruiting1 awardPhase 3
Columbia, Missouri
This trial is testing a medication called GNX to see if it can help reduce seizures in children and adults with epilepsy caused by Tuberous Sclerosis Complex (TSC). The medication works by calming overactive brain signals. The study includes a time to adjust the dosage and a time to see if the treatment is effective.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service